1. Home
  2. DRCT vs JAGX Comparison

DRCT vs JAGX Comparison

Compare DRCT & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

N/A

Current Price

$2.98

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$2.34

Market Cap

2.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRCT
JAGX
Founded
2018
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
DRCT
JAGX
Price
$2.98
$2.34
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$32.00
$60.00
AVG Volume (30 Days)
28.7K
61.1K
Earning Date
05-08-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.42
EPS
N/A
N/A
Revenue
$34,694,000.00
$11,511,000.00
Revenue This Year
$5.42
$61.58
Revenue Next Year
$9.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.22
52 Week High
$7.21
$8.00

Technical Indicators

Market Signals
Indicator
DRCT
JAGX
Relative Strength Index (RSI) 47.66 42.49
Support Level $2.73 $1.74
Resistance Level $2.98 $2.43
Average True Range (ATR) 0.22 0.28
MACD -0.06 -0.15
Stochastic Oscillator 33.32 2.73

Price Performance

Historical Comparison
DRCT
JAGX

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Share on Social Networks: